Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-11 Sale |
2020-12-15 4:47 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) |
View |
| 2020-06-26 Sale |
2020-06-30 7:17 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) |
View |
| 2020-06-19 Sale |
2020-06-23 5:41 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
5,259,492 | $0 | 7,220,655 (Indirect) |
View |
| 2021-03-09 Gift |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
62,500 | $0 | 7,220,655 (Direct) |
View |
| 2020-12-21 Other |
2020-12-23 6:44 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
383,411 | $0 | 12,585,045 (Indirect) |
View |